A detailed history of Hrt Financial LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Hrt Financial LP holds 11,252 shares of UTHR stock, worth $4.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,252
Holding current value
$4.06 Million
% of portfolio
0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $3.5 Million - $4.09 Million
11,252 New
11,252 $4.03 Million
Q1 2024

May 13, 2024

BUY
$210.76 - $249.51 $2.47 Million - $2.92 Million
11,714 Added 209.48%
17,306 $3.98 Million
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $206,284 - $246,662
960 Added 20.73%
5,592 $1.23 Million
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $382,758 - $448,569
1,807 Added 63.96%
4,632 $1.05 Million
Q2 2023

Aug 11, 2023

SELL
$205.19 - $232.99 $6.75 Million - $7.66 Million
-32,876 Reduced 92.09%
2,825 $623,000
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $1.86 Million - $2.41 Million
8,722 Added 32.33%
35,701 $8 Million
Q4 2022

Feb 10, 2023

BUY
$205.95 - $280.43 $4.95 Million - $6.74 Million
24,041 Added 818.28%
26,979 $7.5 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $597,295 - $717,371
2,938 New
2,938 $615,000
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $3.18 Million - $4.39 Million
-18,209 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $2.24 Million - $2.89 Million
13,493 Added 286.11%
18,209 $3.27 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $1.86 Million - $2.18 Million
-10,107 Reduced 68.18%
4,716 $1.02 Million
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $2.67 Million - $3.19 Million
14,823 New
14,823 $2.74 Million
Q2 2021

Aug 16, 2021

SELL
$170.47 - $211.93 $1.02 Million - $1.26 Million
-5,963 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $917,944 - $1.04 Million
5,963 New
5,963 $997,000
Q3 2020

Nov 13, 2020

SELL
$99.9 - $121.13 $1.09 Million - $1.32 Million
-10,904 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$92.74 - $125.82 $1.01 Million - $1.37 Million
10,904 New
10,904 $1.32 Million
Q1 2020

May 15, 2020

SELL
$79.39 - $115.35 $183,549 - $266,689
-2,312 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$78.31 - $95.34 $181,052 - $220,426
2,312 New
2,312 $203,000
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $1.61 Million - $1.85 Million
-21,567 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $1.64 Million - $2.61 Million
21,567 New
21,567 $1.68 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.